FIELD: chemistry.
SUBSTANCE: invention relates to peptide-based compounds containing three-member rings containing a heteroatom, which efficiently and selectively inhibit specific activity of N-terminal nucleophilic (Ntn) hydrolase, bonded with a proteasome. The peptide-based compounds contain epoxide and are functionalised at the N-end.
EFFECT: peptide-based compounds exhibit anti-inflammatory properties and cell proliferation inhibition, oral administration of said peptide-based proteasome inhibitors is possible owing to bioavailability thereof.
23 cl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE EPOXY KETONES FOR PROTEASOME INHIBITION | 2007 |
|
RU2450016C2 |
| HALOGENATED QUINAZOLINE-THF-AMINES AS PDE1 INHIBITORS | 2015 |
|
RU2692808C2 |
| HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS | 2010 |
|
RU2615130C2 |
| INHIBITORS OF MATRIX METALLOPROTEINASES | 2004 |
|
RU2370488C2 |
| CHEMICAL COMPOSITIONS, FORMULATIONS AND METHODS OF THEIR APPLICATION | 2005 |
|
RU2413720C2 |
| SUBSTITUTED AMINO SIX-MEMBER SATURATED HETEROALICYCLES AS LONG-ACTING DPP-IV INHIBITORS | 2016 |
|
RU2720488C2 |
| SUBSTITUTED ARYLPYRAZOLES AS ANTIPARASITIC AGENTS | 2006 |
|
RU2381218C2 |
| PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
| MACROCYCLIC LRRK2 KINASE INHIBITORS | 2012 |
|
RU2622104C2 |
| CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS CONTAINING THEM | 2018 |
|
RU2795146C2 |
